BSEBoard Meeting22 Oct 2026 · 22 Oct 2026, 09:43 am
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026 along with Limited Review Report thereon
Concord Biotech Ltd · 543960
✦ AI SummaryResults
Concord Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 to consider and approve unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026 along with Limited Review Report thereon.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Board Meeting Intimation for Meeting To Be Held On Tuesday, October 27, 2026, Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015